Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure

American Journal of Cardiology

Volumn 88, Issue 1, 2001, Pages 23-29

  Nasser, Ali ^a,b   Dietz, John R ^b   Siddique, Maqsood ^a   Patel, Hamang ^a,b   Khan, Nadim ^a,b   Antwi, Ernest K ^a   San Miguel, Gloria I ^a   McCormick, Michael T ^a   Schocken, Douglas D ^b   Vesely, David L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; KALIURETIC PEPTIDE; PEPTIDE HORMONE; POTASSIUM ION; SODIUM; UNCLASSIFIED DRUG; WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; HUMAN; HYPOTENSION; KALIURESIS; MALE; MICTURITION; NATRIURESIS; PRIORITY JOURNAL; SODIUM RETENTION;

ADULT; AGED; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; CREATININE; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POTASSIUM; PROTEIN PRECURSORS; SODIUM; TREATMENT OUTCOME; URINATION; WATER;

EID: 0035399683     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01579-X     Document Type: Article

References (24)

1. Vessel dilator, long acting natriuretic peptide and kaliuretic peptide: New peptide hormones originating from the atrial natriuretic factor prohormone
2. Congestive heart failure update: New cardiac peptides in diagnosis and treatment
3. Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans
4. 2-terminus are natriuretic and/or kaliuretic
5. Prohormone atrial natriuretic peptide 79-98 (kaliuretic stimulator) lowers blood pressure and increases potassium excretion
6. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans
7. Negative feedback of atrial natriuretic peptides
8. +-ATPase of the atrial natriuretic peptides
9. 2
10. The N-terminus and a 4000 molecular weight peptide from the mid portion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure
11. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
12. Atrial natriuretic factor in normal subjects and heart failure patients
13. Two new hormones: Prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man
14. Change in plasma immunoreactive N-terminus, C-terminus, and 4000 dalton mid portion of atrial natriuretic factor prohormone with hemodialysis
15. Increased release of the N-terminal and C-terminal portions of the pro-hormone of atrial natriuretic factor during immersion-induced central hypervolemia in cirrhotic humans
16. Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans
17. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure
18. Pharmacokinetic characterization of the post-distribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and following rapid right ventricular pacing in dogs
19. Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion
20. Infusion of atrial natriuretic factor prohormone peptides in dogs with experimental heart failure
21. +-ATPase
22. +-ATPase by atrial natriuretic factor in rat renal medullary thick ascending limb of Henle's loop
23. 2